The effect of opiates on the activity of human placental aromatase/CYP19

Biochemical Pharmacology

Volumn 73, Issue 2, 2007, Pages 279-286

  Zharikova, Olga L ^a   Deshmukh, Sujal V ^a   Kumar, Meena ^a   Vargas, Ricardo ^a   Nanovskaya, Tatiana N ^a   Hankins, Gary D V ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aromatase CYP19; Estrogen formation; Human placenta; Opiates; Pregnancy

Indexed keywords

AROMATASE; BENZOMORPHAN DERIVATIVE; CODEINE; DEXTROPROPOXYPHENE; DEXTRORPHAN; DIAMORPHINE; DINORLEVACETYLMETHADOL; ESTRADIOL; ESTRIOL; FENTANYL; HYDROCODONE; HYDROMORPHONE; LEVACETYLMETHADOL; LEVORPHANOL; MORPHINAN DERIVATIVE; MORPHINE; NALOXONE; NALTREXONE; NORACYMETHADOL; OPIATE DERIVATIVE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; PHENANTHRENE DERIVATIVE; PIPERIDINE DERIVATIVE; PLACENTA ENZYME; SUFENTANIL; TESTOSTERONE; TESTOSTERONE DERIVATIVE;

ACUTE DRUG ADMINISTRATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABUSE; DRUG BINDING; DRUG EFFECT; DRUG INDICATION; DRUG INHIBITION; DRUG POTENCY; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; FEMALE; FETUS OUTCOME; HORMONE BINDING; HORMONE INHIBITION; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; IC 50; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL;

AROMATASE; FEMALE; HUMANS; OPIATE ALKALOIDS; PLACENTA;

EID: 33845201044     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.08.019     Document Type: Article

References (23)

1. Challis J.R.G., Mattheus S.G., Gibb W., and Lye S.J. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21 (2002) 514-550
2. Nanovskaya T.N., Deshmukh S., Brooks M., and Ahmed M.S. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 300 (2002) 26-33
3. Nanovskaya T.N., Deshmukh S., Miles R., Burmaster S., and Ahmed M.S. Transfer of l-acetylmethadol (LAAM) and l-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule. J Pharmacol Exp Ther 306 (2003) 205-212
4. Nekhaeva I.A., Nanovskaya T.N., Deshmukh S., Zharikova O.L., Hankins G.D.V., and Ahmed M.S. Bidirectional transfer of methadone across human placenta. Biochem Pharmacol 69 (2005) 187-197
5. Deshmukh S.V., Nanovskaya T.N., and Ahmed M.S. Aromatase is the major enzyme metabolizing buprenorphine in human placenta. J Pharmacol Exp Ther 306 (2003) 1099-1105
6. Deshmukh S.V., Nanovskaya T.N., Hankins G.D.V., and Ahmed M.S. N-demethylation of levo-α-acetylmethadol by human placental aromatase. Biochem Pharmacol 67 (2004) 885-892
7. Nanovskaya T.N., Deshmukh S.V., Nekhaeva I.A., Zharikova O.L., Hankins G.D.V., and Ahmed M.S. Methadone metabolism by human placenta. Biochem Pharmacol 68 (2004) 583-591
8. Thompson E.A., and Siiteri P.K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem 249 (1974) 5373-5378
9. Osawa Y., Higashiyama T., Shimizu Y., and Yarborough C. Multiple function of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase. J Steroid Biochem Mol Biol 44 (1993) 469-480
10. Syme M.R., Paxton J.W., and Keelan J.A. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43 (2004) 487-514
11. Zharikova O.L., Deshmukh S.V., Nanovskaya T.N., Hankins G.D.V., and Ahmed M.S. The effect of methadone and buprenorphine on human placental aromatase. Biochem Pharmacol 71 (2006) 1255-1264
12. Dormitzer C.M., Tonning J.M., Szarfman A., Levine J.G., Calderon S., and Leiderman B. Data mining FDA's post-marketing adverse event reports data to examine drug-dependence reporting. Proceedings of the 68th Annual Scientific Meeting of College on Problems of Drug Dependence. Scottsdale Ariz, 17-22 June 2006 (2006) [abstract 198]
13. Taniguchi H., Feldman H.R., Kaufmann M., and Pyerin W. Fast liquid chromatographic assay of androgen aromatase activity. Anal Biochem 81 (1989) 167-171
14. Hieronymus T., Nanovskaya T.N., Deshmukh S., Vargas R., Hankins G.D.V., and Ahmed M.S. Methadone metabolism by early gestational age placentas. Am J Perinatol 23 (2006) 287-294
15. Facchinetti F., Comitini G., Petraglia F., Volpe A., and Genazzani A.R. Reduced estriol and dehydroepianrosterone sulphate plasma levels in methadone-addicted pregnant women. Eur J Obstet Gynecol Reprod Biol 23 (1986) 67-73
16. Spivack S.D., Hurteau G.J., Reilly A.A., Aldous K.M., Ding X., and Kaminski L.S. CYP1B1 expression in human lung. Drug Metab Dispos 29 (2001) 916-922
17. Price R.J., Renwick A.B., Walters D.G., Young P.J., and Lake B.G. Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicol In Vitro 18 (2004) 179-185
18. Yamazaki H., Shimada T., Martin M.V., and Guengerich P. Stimulation of cytochrome P450 reactions by apo-cytochrome b5. J Biol Chem 276 (2001) 30885-30891
19. Usmani K.A., Rose R.L., and Hodgson E. Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals. Drug Metab Dispos 31 (2003) 384-391
20. Shou M., Grogan J., Mancewicz J.A., Krausz K.W., Gonzalez F.J., Gelboin H.V., et al. Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33 (1994) 6450-6455
21. Szklarz G.D., and Halpert J.R. Molecular basis of P450 inhibition and activation. Implications for drug development and drug therapy. Drug Metab Dispos 26 (1998) 1179-1184
22. Horng J.S., Smith S.E., and Wong D.T. The binding of the optical isomers of methadone to the opiate receptors of rat brain. Res Commun Chem Pathol Pharmacol 14 (1976) 621-629
23. Vaupel D.B., and Jasinski D.R. 1-Alpha-acetylmethadol, 1-alpha-acetyl-N-normethadol and 1-alpha-acetyl-N, N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog. J Pharmacol Exp Ther 283 (1997) 833-842